# VIP Protocol Intelligence Memory Report

## 1. Overview
The Vilo Intelligence Platform (VIP) has been successfully activated in **OBSERVE_CAPTURE_SUGGEST** mode. VIP is now strictly governed as a Memory/Pattern Layer. Autonomous mutation, unapproved training, and direct source modification have been strictly disabled.

## 2. Guardrails Verified
- **Sanitized Patterns:** All abstracted patterns are fully devoid of PHI, PI, and Sponsor-specific text (e.g., specific drug names, CRO names, patient identifiers).
- **No Raw Storage:** VIP does not interact with or store text from the `raw/` or `inbox/` directories.
- **Governed Approval:** All 7 captured seed patterns successfully defaulted to `CANDIDATE` status. No pattern can be applied to production blueprints until manually transitioned to `APPROVED_FOR_REUSE`.
- **Runtime Immutable:** VIP memory creation did not trigger any UI mutation or runtime generation.

## 3. Categorized Memory Seed
VIP successfully processed the validation reports to abstract the following canonical patterns:

| Pattern ID | Category | Abstracted Pattern | Scope | Status |
|---|---|---|---|---|
| **VIP_PAT_...001** | `HARD_STOP_PATTERN` | Eligibility approval (PI signature) MUST occur prior to Randomization/IRT entry. | All Randomized Trials | `CANDIDATE` |
| **VIP_PAT_...002** | `CRITICAL_PROCEDURE_PATTERN` | Ophthalmology Assessment (OCT/Retinal) -> Required for Safety + Eligibility. Needs Specialist Report attachment. | Trials w/ Ocular Toxicity | `CANDIDATE` |
| **VIP_PAT_...003** | `SOURCE_EVIDENCE_PATTERN` | 12-lead ECG -> Requires original machine printout + exact timestamp + PI signature. | Trials capturing ECGs | `CANDIDATE` |
| **VIP_PAT_...004** | `DEVIATION_RISK_PATTERN` | Patient eDiary Training performed after diary issuance -> Compromises primary endpoint. | Trials w/ ePRO | `CANDIDATE` |
| **VIP_PAT_...005** | `COORDINATOR_QA_PATTERN` | Q: Randomization w/ undocumented pregnancy test? A: No, WOCBP require negative result verification. | Interventional Drug Trials | `CANDIDATE` |
| **VIP_PAT_...006** | `SOURCE_BLUEPRINT_PATTERN` | Protocol with IP dosing -> Blueprint MUST generate IP Administration Log + Accountability Log. | Interventional Drug Trials | `CANDIDATE` |
| **VIP_PAT_...007** | `AMENDMENT_IMPACT_PATTERN` | Addition of conditional lab -> Requires Blueprint update, Source versioning, and DOA logs. | Trials w/ Amendments | `CANDIDATE` |

## 4. Engineering Deliverables
1. **Types:** `lib/vip/protocol-intelligence-memory-types.ts`
2. **Logic:** `lib/vip/capture-protocol-intelligence-patterns.ts`
3. **Database Seed:** `validation-corpus/vip-memory/protocol-intelligence-patterns.candidate.json`

## 5. Readiness Assessment
**VIP Protocol Intelligence Memory: `READY`**

The architecture successfully enforces that VIP "learns" from coordinator logic and FDA-level protocol understanding securely, compliantly, and transparently.
